2,770 Cases of Arboviral Disease Reported in 48 States and D.C. in 2023

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on June 17, 2025.

via HealthDay

TUESDAY, June 17, 2025 -- In 2023, 48 states and the District of Columbia reported 2,770 human arboviral disease cases, with West Nile Virus (WNV) being the most common, according to research published in the June 12 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Hannah Padda, D.V.M., from the CDC in Atlanta, and colleagues summarized 2023 data for nationally notifiable domestic arboviral diseases.

The researchers found 2,770 human arboviral disease cases, including 2,022 hospitalizations and 208 deaths (73 and 8 percent, respectively) reported by 48 states and the District of Columbia. In 2023, as in previous years, the most commonly reported domestic arboviral disease was WNV, accounting for 2,628 (95 percent) of all reported cases. Of the case onsets, 91 percent occurred during July to September. In 2023, three WNV disease cases occurred among patients infected through organ transplantation from two donors. The second most common arboviral disease reported was Powassan virus disease (49 cases), which increased from the previous record high in 2022; onsets were evenly distributed during April to December. Among children, La Crosse virus was the most common cause of arboviral disease; most cases were classified as neuroinvasive.

"Arboviral disease testing should be considered by clinicians for patients with an acute febrile or neurologic illness, including recipients of organ transplants or blood transfusions, particularly during times when ticks and mosquitoes are active," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-06-18 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords